Neogen Stock Performance
| NEOG Stock | USD 9.35 0.10 1.08% |
On a scale of 0 to 100, Neogen holds a performance score of 12. The company secures a Beta (Market Risk) of -1.08, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Neogen are expected to decrease slowly. On the other hand, during market turmoil, Neogen is expected to outperform it slightly. Please check Neogen's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Neogen's current price movements will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Neogen are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, Neogen reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 170.6 M | |
| Total Cashflows From Investing Activities | -99.2 M |
Neogen Relative Risk vs. Return Landscape
If you would invest 614.00 in Neogen on October 22, 2025 and sell it today you would earn a total of 320.50 from holding Neogen or generate 52.2% return on investment over 90 days. Neogen is currently generating 0.7847% in daily expected returns and assumes 4.9032% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Neogen, and 85% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Neogen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neogen, and traders can use it to determine the average amount a Neogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.16
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NEOG | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Neogen is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neogen by adding it to a well-diversified portfolio.
Neogen Fundamentals Growth
Neogen Stock prices reflect investors' perceptions of the future prospects and financial health of Neogen, and Neogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neogen Stock performance.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0046 | ||||
| Profit Margin | (0.68) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 2.66 B | ||||
| Shares Outstanding | 217.53 M | ||||
| Price To Earning | 13.36 X | ||||
| Price To Book | 0.96 X | ||||
| Price To Sales | 2.29 X | ||||
| Revenue | 894.66 M | ||||
| EBITDA | (937.75 M) | ||||
| Cash And Equivalents | 347.71 M | ||||
| Cash Per Share | 3.22 X | ||||
| Total Debt | 912.61 M | ||||
| Debt To Equity | 0 % | ||||
| Book Value Per Share | 9.68 X | ||||
| Cash Flow From Operations | 58.24 M | ||||
| Earnings Per Share | (2.78) X | ||||
| Total Asset | 3.44 B | ||||
| Retained Earnings | (536.42 M) | ||||
| Current Asset | 250 M | ||||
| Current Liabilities | 28.6 M | ||||
About Neogen Performance
By analyzing Neogen's fundamental ratios, stakeholders can gain valuable insights into Neogen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neogen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neogen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.Things to note about Neogen performance evaluation
Checking the ongoing alerts about Neogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neogen appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 894.66 M. Net Loss for the year was (1.09 B) with profit before overhead, payroll, taxes, and interest of 404.77 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Is NovoCure A Rare Opportunity After A 45.9 percent One Year Share Price Fall |
- Analyzing Neogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neogen's stock is overvalued or undervalued compared to its peers.
- Examining Neogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neogen's stock. These opinions can provide insight into Neogen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |